This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 05 May 2015  |  Asia Pacific

    Market Trends - Digitalisation, Decentralisation and Democratisation of Healthcare in Australia

    A Market Insight by Frost & Sullivan

    Frost & Sullivan presented the 2015 Australia Healthcare Outlook at a live event in Sydney in March. This document compiles key trends and opinions presented at the event with supporting data and figures. 2015 predictions in the areas of healthcare financing, aged care, primary care, and emerging technologies have been detailed here.

    $850.00
  2. 04 May 2015  |  Asia Pacific

    Market Trends - Technologies to Reduce Healthcare System Fragmentation in Australia

    A Market Insight by Frost & Sullivan

    Frost & Sullivan presented the 2015 Australia Healthcare Information Technology (IT) Outlook at a live event in Sydney in March. This document compiles key trends and opinions presented at the event with supporting data and figures. 2015 predictions highlight key challenges and unmet healthcare industry needs that can be addressed through meaningfu...

    $850.00
  3. This study covers the Russian biopharmaceutical and biomedicine markets. Key segments for the biopharmaceutical market include cytokines, monoclonal antibodies, vaccines, and antibiotics. The biomedicine market includes regenerative medicine, nanomedicine, biocompatible medical materials, diagnostics, post-genomic technologies, and bioinformatics. ...

    $500.00
  4. This issue of Vital Signs, released on July 24, 2014, discusses emerging pharma trends in the Asia Pacific and how the region will act as an anchor to global pharma in coming years, especially in segments such as manufacturing, R&D and clinical trials.

    $500.00
  5. Strong economic growth and increasing public healthcare expenditure has contributed to the growth of healthcare industry in South Korea. The Government is currently focusing on upgrading the healthcare centres, increase the number of healthcare facilities and training programs for doctors. These are expected to result in increased coverage of heal...

    $450.00
  6. After the Asian economic crisis in 1997, the South Korean healthcare industry underwent a phase of overhauling with government initiatives such as the introduction of health insurance and others.These initiatives by the government were aimed at bringing down the costs and increase the competitiveness of the healthcare industry through series of hea...

    $450.00